Regs #200 NFT on XRPL
Regs #200
Collection: Regs
The Regs collection consists of 1000 sophistically curated Regs NFTs generated from an array of 56 hand-drawn attributes.
Issuer: rEguLaToRmmmLRK1tK7EJ5wNJ4RoRncMwv
Taxon: 38903
- Background: Red
- Body: Suit Yellow
- Face: Angry
- Head: Party Hat
- Hand: Mushroom
- Obfuscation Level: 2
NFTokenID: 00080000A11DAA6BCA9291F33ED989CBC503EADB281FC4FEF23DCD5F049DB40D
View and trade this NFT on XRPL.to — the XRP Ledger NFT marketplace.
Frequently Asked Questions about Regs #200
What is Regs #200?
Regs #200 is an XLS-20 NFT on the XRP Ledger from the Regs collection. It has a rarity rank of 278. The NFT has 6 traits. The Regs collection consists of 1000 sophistically curated Regs NFTs generated from an array of 56 hand-drawn attributes.
How do I buy Regs #200?
Regs #200 is not currently listed for sale, but you can place a buy offer through XRPL.to. Connect any XRPL wallet, set your price, and the offer will execute automatically when the owner accepts.
How rare is Regs #200?
Regs #200 has a rarity rank of 278 within the Regs collection. Rarity is calculated from trait frequency — lower rank means rarer combinations of attributes.
What traits does Regs #200 have?
Regs #200 has 6 traits encoded in its NFT metadata. Each trait contributes to the rarity score based on how common or rare that attribute is across the entire Regs.
Who owns Regs #200?
Regs #200 is currently owned by rGPkwRvV3nFatYW7YTKKW4ip35cfd1n3QN. NFT ownership on the XRP Ledger is fully on-chain and transparent — you can verify the current owner at any time on XRPL.to.
What is XLS-20?
XLS-20 is the XRP Ledger's native NFT standard, launched in October 2022. Unlike Ethereum NFTs which require smart contracts, XLS-20 NFTs are built into the XRPL protocol — meaning lower fees, faster settlement, and built-in royalty enforcement. Regs #200 is one of these native XLS-20 tokens.
Properties
Description
The Regs collection consists of 1000 sophistically curated Regs NFTs generated from an array of 56 hand-drawn attributes.